Most Recent Articles by Larry K. Kociolek, MD, MSCI
There remains a need for novel therapeutic strategies, such as a low-trehalose diet, for CDI treatment and prevention, and this is a potential area of future clinical investigation. The clinical benefit of such strategies should be proven before wide-scale changes to trehalose use in food manufacturing are undertaken.
It is important to understand the relative severity of CDI in patients in the ICU because it effects treatment decisions. However, primary prevention remains a vitally important strategy to limit morbidity and mortality related to CDI in this vulnerable patient population.
New guidelines for Clostridium difficile infection call for increased attention to the proper diagnosis and treatment of infectious diseases to guard against the unwarranted use of antibiotic drugs.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Homeopathy No Better Than Placebo for Respiratory Infections in Children
- CDC Director Says Congo Ebola Outbreak May Be Uncontainable
- 10th Child Dies in Adenovirus Outbreak at NJ Facility
- Antibiotics and Failure Rates During 2-Stage Exchange Arthroplasty
- Depression and Alcohol Misuse Lower Odds of Achieving Viral Suppression in HIV
- Oral Urinary Tract Infection Treatments
- Treating Pseudomonas aeruginosa Infections: Highlights From IDWeek 2018
- Local Gentamicin Application Ineffective in Treatment of Periprosthetic Joint Infection
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Social Medicine: The Effect of Social Media on the Anti-Vaccine Movement
- Diarrhea Remains Leading Cause of Global Mortality and Morbidity
- Amoxicillin-Clavulanate Vs Azithromycin for Children With Bronchiectasis
- Online HIV Risk Reduction Intervention Effective in Short Term
- Gentamicin Not Linked to Acute Kidney Injury in Patients with Bacteremia
- GERD Diagnosis and Management Guidelines